Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05546333 · ClinicalTrials.gov registry record
Comparing Electrical Impedance Tomography to Computed Tomographic Angiography
A clinical trial of Pulmonary Embolism, sponsored by Colorado State University.
- Active
- Registry status
- 63
- Enrollment target
- 1
- Study location
NCT05546333: Active study of Pulmonary Embolism, sponsored by Colorado State University.
NCT05546333 is a study of Pulmonary Embolism that is active but no longer recruiting, run by Colorado State University. The registered enrollment target is 63 participants, below the 3,057-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05546333, a study of Pulmonary Embolism, is active but no longer recruiting, sponsored by Colorado State University.
- ACTIVE NOT RECRUITING
- Registry status
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aim is to determine whether electrical impedance tomography (EIT) is equivalent in the detection of pulmomary emboli compared to Computed Tomographic Angiography (CTA). EIT is a non-invasive, non-ionizing functional imaging technique that can be performed at bedside. Electrical impedance tomography data will be collected on individuals undergoing a CTA scan of the chest at Medical Center of the Rockies (MCR). The primary outcome measure is to assess whether assessment by CTA corresponds with EIT in detection of pulmonary emboli. The study will include up to 63 participants. EIT data will be collected for up to 20 minutes during tidal breathing and for approximately five to ten seconds during breath-holding.
Primary Outcome
To assess whether assessment by CTA corresponds with EIT in detection of pulmonary emboli (PE).
Conditions Studied
Interventions
- DEVICE Electrical impedance tomography
Study Locations (1)
Colorado
- UCHealth Medical Center of the Rockies - Loveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-06-09 |
What the registry record for NCT05546333 still lists
NCT05546333 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 3,057-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Electrical impedance tomography is the first listed.
NCT05546333 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05546333 about?
NCT05546333 is a clinical study titled "Comparing Electrical Impedance Tomography to Computed Tomographic Angiography". The study aim is to determine whether electrical impedance tomography (EIT) is equivalent in the detection of pulmomary emboli compared to Computed Tomographic Angiography (CTA). EIT is a non-invasive, non-ionizing functional imaging technique that can be performed at bedside. Electrical impedance t...
What is the current status of trial NCT05546333?
This trial is currently active not recruiting. The enrollment target is 63 participants. The study started on 2023-05-01. Estimated completion is 2026-06-09.
What conditions does trial NCT05546333 study?
This clinical trial studies the following conditions: Pulmonary Embolism.
What interventions are being tested in trial NCT05546333?
The interventions under investigation include: Electrical impedance tomography (DEVICE).
Who is sponsoring clinical trial NCT05546333?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05546333 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05546333's enrollment target sits among peer trials
63 41st of 48 higher than 8 of 48 other Pulmonary Embolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Embolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
RECRUITING
-
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI